Dr Jesse Rye Beaudry, PHARMD | |
59 Page Hill Rd, Berlin, NH 03570-3531 | |
(603) 326-5863 | |
Not Available |
Full Name | Dr Jesse Rye Beaudry |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 59 Page Hill Rd, Berlin, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184963506 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 3907 (New Hampshire) | Primary |
183500000X | Pharmacist | PR12910 (Maine) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Jesse Rye Beaudry, PHARMD 59 Page Hill Rd, Berlin, NH 03570-3531 Ph: (603) 326-5863 | Dr Jesse Rye Beaudry, PHARMD 59 Page Hill Rd, Berlin, NH 03570-3531 Ph: (603) 326-5863 |
News Archive
A panel of autism experts at a meeting of the American Association for the Advancement of Science, have presented reports which comment on the assumptions about the developmental disability.
Women with low levels of sexual desire, often as a result of menopause, are more likely to be depressed and to suffer physical symptoms such as back pain and memory problems than women who report higher levels of desire, according to a new study by researchers at the University of North Carolina at Chapel Hill and Procter & Gamble Pharmaceuticals.
The results of a new study on immune-based treatment of Alzheimer's disease (AD), which was conducted at 30 sites around the country, will be published in the December 15 issue of Neurology®. Lead author, Stephen P. Salloway, MD, MS, director of the Butler Hospital Memory and Aging Program and a professor of neurology and psychiatry at the Warren Alpert Medical School of Brown University, says that this 18-month phase two study on slowing the disease process in Alzheimer's patients offers promising results.
Research indicates that widespread opioid overprescribing contributed to the opioid epidemic.
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.
› Verified 4 days ago
Jessica Marie Remillard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 85 Hinchey Street, Berlin, NH 03570 Phone: 603-986-3910 | |
Mr. Todd Lukaszewski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Pleasant St, Berlin, NH 03570 Phone: 603-752-3952 | |
Miss Paige Houlihan Kane, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Pleasant St, Berlin, NH 03570 Phone: 603-752-3952 Fax: 603-752-4925 | |
Thomas Tran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 59 Page Hill Rd, Berlin, NH 03570 Phone: 603-752-3882 | |
Cynthia Ann Desmond, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Pleasant St, Berlin, NH 03570 Phone: 603-752-3952 | |
Dr. Craig Lozier, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Pleasant St, Berlin, NH 03570 Phone: 603-752-3952 Fax: 603-752-4952 |